...
首页> 外文期刊>Gerontology: International Journal of Experimental and Clinical Gerontology >The Matrisome during Aging and Longevity: A Systems-Level Approach toward Defining Matreotypes Promoting Healthy Aging
【24h】

The Matrisome during Aging and Longevity: A Systems-Level Approach toward Defining Matreotypes Promoting Healthy Aging

机译:老化和寿命期间的矩阵:朝向促进健康老化的损失型的系统水平方法

获取原文
获取原文并翻译 | 示例
           

摘要

Accumulation of damage is generally considered the cause of aging. Interventions that delay aging mobilize mechanisms that protect and repair cellular components. Consequently, research has been focused on studying the protective and homeostatic mechanisms within cells. However, in humans and other multicellular organisms, cells are surrounded by extracellular matrices (ECMs), which are important for tissue structure, function, and intercellular communication. During aging, components of the ECM become damaged through fragmentation, glycation, crosslinking, and accumulation of protein aggregation, all of which contribute to age-related pathologies. Interestingly, placing senescent cells into a young ECM rejuvenates them. Furthermore, we found that many longevity-assurances pathways reactivate de novo synthesis of ECM proteins during aging. This raises the question of what constitutes a young ECM to reverse aging or maintain health? In order to make inroads to answering this question, I suggest a systems-level approach of quantifying the matrisome or ECM compositions reflecting health, pathology, or phenotype and propose a novel term, the "matreotype," to describe this. The matreotype is defined as the composition and modification of ECM or matrisome proteins associated with or caused by a phenotype, such as longevity, or a distinct and acute physiological state, as observed during aging or disease. Every cell type produces its unique ECM. Intriguingly, cancer-cell types can even be identified based on their unique ECM composition. Thus, the matreotype reflects cellular identity and physiological status. Defined matreotypes could be used as biomarkers or prognostic factors for disease or health status during aging with potential relevance for personalized medicine. Treatment with biologics that alter ECM-to-cell mechanotransduction might be a strategy to reverse age-associated pathologies. An understanding of how to reverse from an old to a young matreotype might point toward novel strategies to rejuvenate cells and help maintain tissue homeostasis to promote health during aging.
机译:损害的积累通常被认为是老化的原因。延迟老化动员机制的干预机制保护和修复细胞组分。因此,研究已经专注于研究细胞内的保护和稳态机制。然而,在人类和其他多细胞生物中,细胞被细胞外基质(ECMS)包围,这对于组织结构,功能和细胞间通信很重要。在衰老期间,ECM的组分通过碎片,甘露解,交联和蛋白质聚集的累积而受损,所有这些都有助于与年龄相关的病理学。有趣的是,将衰老细胞放入年轻的ECM中恢复活力。此外,我们发现许多寿命保证途径重新衰老的Novo合成ECM蛋白。这提出了一个关于逆转老化或维持健康的年轻ECM的问题的问题?为了进入回答这个问题,我建议量化矩阵或ECM组合物的系统级方法,反映了健康,病理学或表型并提出一种新术语,“matreotype”来描述这一点。如在老化或疾病期间所观察到的,定义了与由衰老或疾病所观察到的表型相关或由表型或不同和急性生理状态相关的ECM或矩阵蛋白的组成和修饰。每种细胞类型都会产生其独特的ECM。有趣的是,甚至可以基于其独特的ECM组成来识别癌细胞类型。因此,matreotype反映了细胞身份和生理状态。定义的matreotypes可用作老化期间患者疾病或健康状况的生物标志物或预后因素,其具有个性化医学的潜在相关性。改变ECM-细胞机电机组的生物学治疗可能是逆转年龄相关病理的策略。了解如何从旧的matreotype逆转可能指出新的策略来恢复细胞,并帮助维持组织稳态在老龄化期间促进健康。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号